Authors:
Agaoglu, L
Devecioglu, O
Anak, S
Karakas, Z
Yalman, N
Biner, B
Eryilmaz, E
Goksan, B
Unuvar, A
Agirbasli, H
Can, M
Bilgen, H
Gedikoglu, G
Citation: L. Agaoglu et al., Cost-effectiveness of cefepime plus netilmicin or ceftazidime plus amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey, J CHEMOTHER, 13(3), 2001, pp. 281-287
Authors:
Poon, MC
d'Oiron, R
Hann, I
Negrier, C
de Lumley, L
Thomas, A
Karafoulidou, A
Demers, C
Street, A
Huth-Kuhne, A
Petrini, P
Fressinaud, E
Morfini, M
Tengborn, L
Marques-Verdier, A
Musso, R
Devecioglu, O
Houston, DS
Lethagen, S
Van Geet, C
von Depka, M
Berger, C
Beurrier, P
Britton, HA
Gerrits, W
Guthner, C
Kuhle, S
Lorenzo, JJ
Makris, PE
Nohe, N
Paugy, P
Pautard, B
Torchet, MF
Trillot, N
Vicariot, M
Wilde, J
Winter, M
Chambost, H
Ingerslev, J
Peters, M
Strauss, G
Citation: Mc. Poon et al., Use of recombinant factor VIIa (NovoSeven (R)) in patients with Glanzmann thrombasthenia, SEM HEMATOL, 38(4), 2001, pp. 21-25
Authors:
Sarper, N
Ozbek, U
Agaoglu, L
Ozgen, U
Eryilmaz, E
Yalman, N
Anak, S
Devecioglu, O
Gedikoglu, G
Citation: N. Sarper et al., Is AML1/ETO gene expression a good prognostic factor in pediatric acute myeloblastic leukemia?, PED HEM ONC, 17(7), 2000, pp. 577-583
Authors:
Devecioglu, O
Biner, B
Karabocuoglu, M
Unuvar, A
Agaoglu, L
Citation: O. Devecioglu et al., Systemic near-fatal anaphylactic reaction after intrathecal methotrexate administration, MED PED ONC, 34(2), 2000, pp. 151-152